Effects on Pancreatic Insulin Secretion

Halki Diabetes Remedy

Diabetes Causes and Treatment

Get Instant Access

Clinical use of thiazolidinediones consistently results in reduced plasma insulin levels and reduced insulin requirements in patients with type 2 diabetes taking insulin, reflecting an increase in insulin sensitivity. Although these agents do not directly stimulate P-cell insulin secretion, studies indicate that they can restore aspects of defective glucose-coupled insulin responsiveness in humans and animals with type 2 diabetes.

There are several potential mechanisms whereby thiazolidinediones might enhance P-cell function, in addition to simply lowering ambient levels of glycemia and reducing "glucotoxic" signaling abnormalities in P-cells. Recently, abnormal P-cell secretory responsiveness and potential cell death (apoptosis) have been attributed to chronic effects of accumulated triglycerides and FFA derivatives in the pancreatic islet cells in obesity with insulin resistance, a phenomenon that has been dubbed "lipotoxicity" [12,13]. This hypothesis also postulates that the effect of thiazolidinediones to redistribute fat stores in the body, including from the pancreatic islets, and to reduce circulating levels of FFA, may improve P-cell function [14]. In diabetes-prone, obese rodents, pre-clinical data has shown a potent effect of thiazolidinediones to restore P-cell insulin content and preventing loss of P-cell mass in models of type 2 diabetes [12,15,16].

Was this article helpful?

0 0
Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment